易方达标普生物科技人民币C(012866)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2023-12-31 | RVMD | Revolution Medicines Inc | 买入 | 257.84 | 0.8% |
| 2023-12-31 | PTGX | Protagonist Therapeutics Inc | 卖出 | 254.18 | 0.78% |
| 2023-12-31 | RXRX | Recursion Pharmaceuticals Inc-A | 买入 | 253.78 | 0.78% |
| 2023-12-31 | TWST | Twist Bioscience Corp | 卖出 | 252.51 | 0.78% |
| 2023-12-31 | MORF | Morphic Holding Inc | 买入 | 249.66 | 0.77% |
| 2023-12-31 | SAGE | Sage Therapeutics Inc | 买入 | 248.26 | 0.77% |
| 2023-12-31 | BMEA | Biomea Fusion Inc | 买入 | 238.7 | 0.74% |
| 2023-12-31 | SRPT | Sarepta Therapeutics Inc | 买入 | 230.75 | 0.71% |
| 2023-12-31 | REPL | Replimune Group Inc | 买入 | 226.64 | 0.7% |
| 2023-12-31 | EXAS | 精密科学 | 卖出 | 223.52 | 0.69% |
| 2023-12-31 | FATE | Fate Therapeutics Inc | 买入 | 223.03 | 0.69% |
| 2023-12-31 | PTCT | PTC Therapeutics Inc | 买入 | 224.81 | 0.69% |
| 2023-12-31 | TGTX | TG Therapeutics Inc | 买入 | 216.16 | 0.67% |
| 2023-12-31 | APLS | Apellis Pharmaceuticals Inc | 买入 | 209.31 | 0.65% |
| 2023-12-31 | INCY | 因塞特医疗 | 买入 | 200.24 | 0.62% |
| 2023-12-31 | RNA | Avidity Biosciences Inc | 买入 | 190.62 | 0.59% |
| 2023-06-30 | IMGN | ImmunoGen Inc | 卖出 | 778.67 | 2.4% |
| 2023-06-30 | MDGL | Madrigal Pharmaceuticals Inc | 卖出 | 695.64 | 2.15% |
| 2023-06-30 | RXDX | Prometheus Biosciences Inc | 卖出 | 518.13 | 1.6% |
| 2023-06-30 | CTIC | CTI BioPharma Corp | 卖出 | 457.37 | 1.41% |
公告&资料
